In country partners for the Malaria Program include the Bureau of Public Health, working arm of the Ministry of Health responsible for the insurance of quality health care, surveillance and monitoring in Suriname, the Medical Mission, responsible for primary health care in the Interior of the country and the Institute for Biomedical Sciences, which is, among other things, active in drug quality and drug resistance research.
The Malaria Program has a continuous exchange of information with The Bureau of Public Health, both the Anti-Malaria Campaign Department and the Epidemiology Department on malaria cases in general, and the ones reported by the hospitals and private laboratories especially.
The Medical Mission is responsible for malaria diagnosis and treatment in the stable populations of the Interior and supports the Malaria Program in its bed net distribution activities.
The Malaria Program and the Institute for Biomedical Sciences in Suriname (MWI) are cooperating on the introduction of molecular screening with Real-Time PET PCR for malaria identification (even with very low parasitaemia). The idea is to set up malaria serology in Suriname and introduce serological testing to allow the country to gradually declare areas of the territory free from malaria. In addition the emerging of Artemisinin resistance can be assessed through molecular characterizations and drug sensitivity studies.
Suriname is part of the Amazon Network for the Surveillance of Anti- malarial Drug Resistance (RAVREDA) and the Amazone Malaria Initiative (AMI). The RAVREDA network was organized in 2001 by several countries of the Amazon subregion, with PAHO, to respond to the challenge of antimalarial drug resistance in the Amazon. The AMI was also launched in 2001 by the United States Agency for International Development, Office for Infectious Diseases in Latin America and the Caribbean (USAID/LAC) as its mechanism for focusing its financial and technical resources in support of the Roll Back Malaria Partnership (RBM) in Latin America.
Other at risk groups besides mobile illegal miners are stabile populations of villages near the mining areas, legal miners and loggers. The last group is vulnerable because they move in between concession areas and because the largest logging company employs loggers and supporting personnel from Guyana as well as Suriname. Guyana still has a significant malaria problem and relative import of malaria from Guyana in Suriname increased over the past years. New partnerships with companies active in logging and mining in Suriname are being made as part of the prevention and control strategy. Memoranda of Understanding have been established with some of these partners with an aim to promote ownership and sustainability of malaria prevention and control efforts.
Last, but not least, there is a continuous communication with neighboring countries for the exchange of epidemiological data and to support international cooperation.